Medicus Pharma Ltd. Commo... (MDCX)
| Bid | 2.46 |
| Market Cap | 39.44M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -9.36M |
| EPS (ttm) | -1.37 |
| PE Ratio (ttm) | -1.81 |
| Forward PE | -2.69 |
| Analyst | Strong Buy |
| Ask | 2.49 |
| Volume | 38,126 |
| Avg. Volume (20D) | 256,174.9 |
| Open | 2.51 |
| Previous Close | 2.49 |
| Day's Range | 2.42 - 2.54 |
| 52-Week Range | 1.80 - 8.94 |
| Beta | -2.57 |
About MDCX
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for MDCX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
Just now · proactiveinvestors.com
Medicus Pharma names Andrew Smith as COO, advances BCC and prostate drug studiesMedicus Pharma (NASDAQ:MDCX) said on Monday it has appointed Andrew Smith as chief operating officer, bringing on board a seasoned asset management executive as the company accelerates its clinical de...
1 week ago · proactiveinvestors.com
Medicus Pharma submits FDA plan to develop microneedle-based treatment for skin cancer in horsesMedicus Pharma (NASDAQ:MDCX) said on Monday it has submitted a comprehensive product development plan to the US Food and Drug Administration (FDA) to advance its investigational treatment for external...
2 weeks ago · proactiveinvestors.com
Medicus Pharma appoints KPMG as new auditor, expands global clinical programsMedicus Pharma (NASDAQ:MDCX) said it has appointed KPMG as its independent registered public accounting firm for the 2025 fiscal year, replacing EisnerAmper following a review process led by the compa...
3 weeks ago · newsfilecorp.com
Medicus Pharma Ltd. Announces Closing of $7.0 Million Public OfferingPhiladelphia, Pennsylvania--(Newsfile Corp. - June 2, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the closing of its previously announced public offering of 2,260,000 un...
3 weeks ago · newsfilecorp.com
Medicus Pharma Ltd. Announces Pricing of $7.0 Million Public OfferingPhiladelphia, Pennsylvania--(Newsfile Corp. - May 29, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the pricing of its public offering of 2,260,000 units, on a "best-effor...